4//SEC Filing
Beebe Katherine 4
Accession 0001104659-22-001617
CIK 0000910267other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:50 PM ET
Size
5.3 KB
Accession
0001104659-22-001617
Insider Transaction Report
Form 4
Beebe Katherine
Chief Scientific Officer
Transactions
- Award
Option to Purchase Common Stock
2022-01-05+55,000→ 55,000 totalExercise: $1.18Exp: 2032-01-05→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001768867
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:50 PM ET
- Size
- 5.3 KB